Need Help?

High Altitude Pulmonary Hypertension

The Central Asian Kyrgyz highland population provides a unique opportunity to address genetic diversity and understand the genetic mechanisms underlying hypoxia-induced high altitude pulmonary hypertension (HAPH). While a significant fraction of the population is unaffected, there are susceptible individuals who display HAPH in the absence of any lung, cardiac or hematologic disease. We report herein the analysis of the whole genome sequencing of healthy individuals compared with HAPH patients and other controls. In this study, 34 male individuals from Central Asian Kyrgyz highland are sequenced with Illumina HiSeq 2000 with mean-coverage of 30X.

Request Access

Genesis of hyperreactivity of the pulmonary vessels

We would like to invite you to participate in a research project. You should not take part in the study if you do not wish to do so. If you do decide to take part, please let us know beforehand if you have been involved in any other study during the last year. You are free to withdraw at any time without explanation. We would like you to attend our hospitaI. In a first we will check your health, by examining you and sending some blood for routine hematology, biochemistry and DNA for genetic study. The DNA will be used only for study the role of gene candidates in genesis of hyperreactivity of the pulmonary vessels. All DNA will be coded without using patient's name. On the second you will have a small tube (catheter) placed through a vein in your neck through to your heart to record blood pressure. You will then breathe a low oxygen gas mixture for 30 minutes. During this period your blood pressure will be recorded. In 30 minutes of breathe we will take the blood samples for biochemistry. After this the catheter will be removed. If you decide to take part in this study you should sign the participant consent form. The local Research Ethics Committee has approved the above statement.

Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.

Study ID Study Title Study Type
EGAS00001003171 Other

This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.

ID File Type Size Located in
EGAF00002066535 bam 77.0 GB
EGAF00002066536 bam 73.3 GB
EGAF00002066537 bam 81.2 GB
EGAF00002066538 bam 64.8 GB
EGAF00002066539 bam 84.4 GB
EGAF00002066540 bam 97.5 GB
EGAF00002066541 bam 97.3 GB
EGAF00002066542 bam 81.1 GB
EGAF00002066543 bam 77.0 GB
EGAF00002066544 bam 69.9 GB
EGAF00002066545 bam 74.3 GB
EGAF00002066546 bam 82.0 GB
EGAF00002066547 bam 80.7 GB
EGAF00002066548 bam 82.9 GB
EGAF00002066549 bam 73.5 GB
EGAF00002066550 bam 73.3 GB
EGAF00002066551 bam 77.4 GB
EGAF00002066552 bam 83.1 GB
EGAF00002066553 bam 111.0 GB
EGAF00002066554 bam 106.7 GB
EGAF00002066555 bam 98.2 GB
EGAF00002066556 bam 108.0 GB
EGAF00002066557 bam 78.8 GB
EGAF00002066558 bam 104.4 GB
EGAF00002066559 bam 78.1 GB
EGAF00002066560 bam 75.6 GB
EGAF00002066561 bam 74.5 GB
EGAF00002066562 bam 88.9 GB
EGAF00002066563 bam 80.9 GB
EGAF00002066564 bam 74.7 GB
EGAF00002066565 bam 81.1 GB
EGAF00002066566 bam 81.9 GB
EGAF00002066567 bam 80.1 GB
EGAF00002066568 bam 78.9 GB
34 Files (2.8 TB)